IgE hyperproduction through enhanced tyrosine phosphorylation of janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 1056-1063

  Matsumoto, Masahiro ^a,b   Ra, Chisei ^c   Kawamoto, Keiko ^a,c   Sato, Hiroaki ^a   Itakura, Atsuko ^a   Sawada, Junko ^a   Ushio, Hiroko ^a   Suto, Hajime ^c   Mitsuishi, Kouichi ^c   Hikasa, Yoshiaki ^d   Matsuda, Hiroshi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 4; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; ATOPIC DERMATITIS; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ALUMINUM HYDROXIDE; ANIMALS; ANTIGENS, CD40; ANTIGENS, THY-1; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELLS, CULTURED; COCULTURE TECHNIQUES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNIZATION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; JANUS KINASE 3; LIGANDS; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; OVALBUMIN; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; TYROSINE;

EID: 0033555894     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Cooper, K. D. 1994. Atopic dermatitis: recent trends in pathogenesis and therapy. J. Invest. Dermatol. 102:128.
2. Horan, R. F., L. C. Schneider, and A. L. Sheffer. 1992. Allergic skin disorders and mastocytosis. JAMA 268:2858.
3. Ohmen, J. D., J. M. Hanifin, B. J. Nickoloff, T. H. Rea, R. Wyzykowski, J. Kim, D. Jullien, T. McHugh, A. S. Nassif, S. C. Chan, et al. 1995. Overexpression of IL-10 in atopic dermatitis: contrasting cytokine patterns with delayed-type hypersensitivity reactions. J. Immunol. 154:1956.
4. Kay, A. B., S. Ying, V. Varney, M. Gaga, S. R. Durham, R. Moqbel, A. J. Wardlaw, and Q. Hamid. 1991. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, ard granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Exp. Med. 173:775.
5. Rousset, F., J. Robert, M. Andary, J.-P. Bonnin, G. Souillet, I. Chretien, F. Briere, J. Pene, and J. E. de Vries. 1991. Shifts in interleukin-4 and interferon-γ production by T cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J. Allergy Clin. Immunol. 87:58.
6. Reinhold, U., W. Wehrmann, S. Kukel, and H. W. Kreysel. 1990. Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin. Exp. Immunol. 79:374.
7. Renz, H., K. Jujo, K. L. Bradley, J. Domenico, E. W. Gelfand, and D. Y. M. Leung. 1992. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-γ. J. Invest. Dermatol. 99:403.
8. Renz, H., C. Brodie, K. Bradley, D. Y. M. Leung, and E. W. Gelfand. 1994. Enhancement of IgE production by anti-CD40 antibody in atopic dermatitis. J. Allergy Clin. Immunol. 93:658.
9. Jujo, K., H. Renz, J. Abe, A. Trumble, E. W. Gelfand, and D. Y. M. Leung. 1993. Pokeweed mitogen induces IgE synthesis in the presence of a blocking antibody to the interferon-γ receptor. J. Allergy Clin. Immunol. 91:1206.
10. Lester, M. R., M. F. Hofer, M. Gately, A. Trumhle, and D. Y. M. Leung. 1995. Down-regulating effects of IL-4 and IL-10 on the IFN-γ response in atopic dermatitis. J. Immunol. 154:6174.
11. Kondo, K., T. Nagami, and S. Tadokoro. 1969. Differences in haematopoietic death among inbred strains of mice. In Comparative Cellular and Species Radiosensitivity. P. V. Bond and T. Sugawara, eds. Igakushoin, Tokyo, p. 20.
12. Festing, M. F. W. 1996. Origins and characteristics of inbred strains of mice. In Genetic Variants and Strains of the Laboratory Mouse, erd Ed. M. F. Lyon, S. Rastan, and S. D. M. Brown, eds. Oxford University Press, Oxford, p. 1537.
13. Matsuda, H., N. Watanabe, G. P. Geba, J. Sperl, M. Tsudzuki, J. Hiroi, M. Matsumoto, H. Ushio, S. Saito, P. W. Askenase, et al. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9:461.
14. Kopf, M., G. Le Gros, M. Bachmann, M. C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245.
15. Renshaw, B. R., W. C. Fanslow III, R. J. Armitage, K. A. Campbell, D. Liggitt, B. Wright, B. L. Davison, and C. R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889.
16. Castigli, E., F. W. Alt. L. Davidson, A. Bottaro, E. Mizoguchi, A. K. Bhan, and R. S. Geha. 1994. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc. Natl. Acad. Sci. USA 91:12135.
17. Aruffo, A., M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L. S. Grosmaire, R. Stenkamp, M. Neubauer, et al. 1993. The CD40 ligand, gp39, is defective in activated T ceils from patients with X-linked hyper-IgM syndrome. Cell 72:291.
18. Korthauer, U., D. Graf, H. W. Mages, F. Briere, M. Padayachee, S. Malcolm, A. G. Ugazio, L. D. Notarangelo, R. J. Levinsky, and R. A. Kroczek. 1993 Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539.
19. DiSanto, J. P., J. Y. Bonnefoy, J. F. Gauchat, A. Fischer, and G. de Saint Bacile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361:541.
20. Allen, R. C., R. J. Armitage, M. E. Conley, H. Rosenblatt, N. A. Jenkins, N. G. Copeland, M. A. Bedell, S. Edelhoff, C. M. Disteche, D. K. Simoneaux, et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:99.
21. Fuleihan, R., N. Ramesh, R. Loh, H. Jabara, F. S. Rosen, T. Chatila, S. M. Fu, I. Stamenkovic, and R. S. Geha. 1993. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA 90:2170.
22. Foy, T. M., D. M. Shepherd, F. H. Durie, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymusdependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567.
23. Gauchat, J.-F., D. A. Lebman, R. L. Coffman, H. Gascan, and J. E. de Vries. 1990. Structure and expression of germline ∈ transcripts in human B cells induced by interleukin 4 to switch to IgE production. J. Exp. Med. 172:463.
24. Spriggs, M. K., R. J. Armitage, L. Strockbine, K. N. Clifford, B. M. Macduff, T. A. Sato, C. R. Maliszewski, and W. C. Fanslow. 1992. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176:1543.
25. Armitage, R. J., W. C. Fanslow, L. Strockbine, T. A. Sato, K. N. Clifford, B. M. Macduff, D. M. Anderson, S. D. Gimpel, T. Davis-Smith, C. R. Maliszewski, et al. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357:80.
26. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnel. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177:1209.
27. Jabara, H. H., S. M. Fu, R. S. Geha, and D. Vercelli. 1990. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172:1861.
28. Coffman, R. L., and J. Cany. 1986. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ. J. Immunol. 136:949.
29. Coffman, R. L., J. Ohara, M. W. Bond, J. Carry, A. Zlotnik, and W. E. Paul. 1986. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J. Immunol. 136:4538.
30. Azuma, M., T. Hirano, H. Miyajima, N. Watanabe, H. Yagita, S. Enomoto, S. Furusawa, Z. Ovary, T. Kinashi, T. Honjo, et al. 1987. Regulation of murine IgE production in SJA/9 and nude mice: potentiation of IgE production by recombinant interleukin 4. J. Immunol. 139:2538.
31. Maeda-Yoshimoto, K., T. Hirano, H. Miyajima, T. Nagate, K. Hanada, S. Hirose, K. Okumura, and Z. Ovary. 1994. Suppression of IgE production in unseparated spleen cell cultures. Cell. Immunol. 153:277.
32. Wu. C. Y., M. Sarfati, C. Heusser, S. Fournier, M. Rubio-Trujillo, R. Peleman, and G. Delespesse. 1991. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes. J. Clin. Invest. 87:870.
33. Jahara, H. H., D. J. Ahern, D. Vercelli, and R. S. Geha. 1991. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J. Immunol. 147:1557.
34. Ohara, J., and W. E. Paul. 1987. Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage. Nature 325:537.
35. Park. L. S., D. Friend, K. Grabstein, and D. L. Urdal. 1987. Characterization of the high-affinity cell-surface receptor for murine B-cell-stimulating factor 1. Proc. Natl. Acad. Sci. USA 84:1669.
36. Kondo, M., T. Takeshita, N. Ishii, M. Nakamura, S. Walanabe, K. Arai, and K. Sugamura. 1993. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for IL-2 and IL-4. Science 262:1874.
37. Noguchi, M., Y. Nakamura, S. M. Russel, S. F. Ziegler, M. Tsang, X. Cao, and W. J. Leonard. 1993. Interleukin-2 receptor γ chain: A functional component of the interleukin-7 receptor. Science 261:1877.
38. Russell, S. M., A. D. Keegan, N. Harada, Y. Nakamura, M. Noguchi, P. Leland, M. C. Friedmann, A. Miyajima, R. K. Puri, W. E. Paul, et al. 1993. Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science 262:1800.
39. Kondo, M., T. Takeshita, M. Higuchi, M. Nakamura, T. Sudo, S. Nishikawa, and K. Sugamura. 1994. Functional participation of the IL-2 receptor γ chain in IL-7 receptor complexes. Science 263:1453.
40. Russell, S. M., J. A. Johnslon, M. Noguchi, M. Kawamura, C. M. Bacon, M. Friedmann, M. Berg, D. W. McVicar, B. A. Witthuhn, O. Silvennoinen, et al. 1994. Interaction of IL-2Rβ and γc chains with Jak1 and Jak3: implications for XSCID and XCID. Science 266:1042.
41. Giri, J. G., M. Ahdieh, J. Eisenman, K. Shanebeck, K. Grabstein, S. Kumaki, A. Namen, L. S. Park, D. Cosman, and D. Anderson. 1994. Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 13:2822.
42. Miyazaki, T., A. Kawahara, H. Fujii, Y. Nakagawa, Y. Minami, Z.-J. Liu, I. Oishi, O. Silvennoinen, B. A. Witthuhn, J. N. Ihle, et al. 1994. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266:1045.
43. Witthuhn, B. A., O. Silvennoinen, O. Miura, K. S. Lai, C. Cwik, E. T. Liu, and J. N. Ihle. 1994. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153.
44. Tortolani, P. J., B. K. Lal, A. Riva, J. A. Jobnston, Y.-Q. Chen, G. H. Reaman, M. Beckwith, D. Longo, J. R. Onaldo, K. Bhatia, et al. 1995. Regulation of JAK3 expression and activation in human B cells and B cell malignancies. J. Immunol. 155:5220.
45. Ihle, J. N. 1995. Cytokine receptor signalling. Nature 377:591.
46. Hanissian, S. H., and R. S. Geha. 1997. JAK3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6:379.
47. Ushio, H., S. Hirota, T. Jippo, S. Higuchi, K. Kawamoto, Y. Kitamura, and H. Matsuda. 1995. Mechanisms of eosinophilia in mice infested with larval Haemophysalis longicornis ticks. Immunology 84:469.
48. + T cells. J. Immunol. 151:2497.
49. Fulcihan, R., N. Ramesh, A. Horner, D. Ahem, P. J. Belshaw, and D. G. Alberg, I. Stamenkovic, W. Harmon, and R. S. Geha. 1994. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J. Clin. Invest. 93:1315.
50. Matsuda, H., N. Watanabe, Y. Kiso, S. Hirota, H. Ushio, Y. Kannan, M. Azuma, H. Koyama, and Y. Kitamura. 1990. Necessity of IgE antibodies and mast cells for manifestation of resistance against larval Haemaphysalis longicornis ticks in mice. J. Immunol. 144:259.
51. Katagiri, K., S. Itami, Y. Hatano, and S. Takayasu. 1997. Increased levels of IL-13 mRNA, but not IL-4 mRNA, are found in vivo in peripheral blood mononuclear cells (PBMC) of patients with atopic dermatitis. (AD). Clin. Exp. Immunol. 108:289.
52. Horsmanheimo, L., L. T. Harvima, A. Jarvikallio, R. J. Harvima, A. Naukkarinen, and M. Horsmanheimo. 1994. Mast cells are one major source of interleukin-4 in atopic dermatitis. Br. J. Dermatol. 131:348.
53. + allergen-specific T lymphocytes in atopic dermatitis lesional skin. J. Invest. Dermatol. 97:389.
54. Ricci, M. 1994. IL-4: a key cytokine in atopy. Clin. Exp. Allergy 24:801.
55. Johnston, J. A., M. Kawamura, R. A. Kirken, Y.-Q. Chen, T. B. Blake, K. Shibuya, J. R. Ortaldo, D. W. McVicar, and J. J. O'Shea. 1994. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 370:150.
56. Hershey, G. K., M. F. Friedrich, L. A. Esswein, M. L. Thomas, and T. A. Chatila. 1997. The association of atopy with a gain-of-function mutation in the α subunit of the interleukin-4 receptor. N. Engl. J. Med. 337:1720.
57. Imani, F., K. J. Rager, B. Catipovic, and D. G. Marsh. 1997. Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation: implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J. Biol. Chem. 272:7917.
58. Klingmuller, U., U. Lorenz, L. C. Cantley, B. G. Neel, and H. F. Lodish. 1995. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80:729.
59. Schulte, T., R. Kurrle, M. Rollinghoff, and A. Gessner. 1997. Molecular characterization and functional analysis of murine interleukin 4 receptor allotypes. J. Exp. Med. 186:1419.